Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $2.68, but opened at $2.95. Taysha Gene Therapies shares last traded at $3.12, with a volume of 1,228,318 shares trading hands. Analyst Ratings Changes A number of equities analysts have recently […]
Williams & Novak LLC acquired a new position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 45,000 shares of the company’s stock, valued at approximately $80,000. Several other hedge funds and other institutional […]
Investment Analysts’ new coverage for Tuesday, April 9th: Guggenheim initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN). Guggenheim issued a buy rating and a $55.00 price target on the stock. Needham & Company LLC assumed coverage on shares of Amkor Technology (NASDAQ:AMKR). The firm issued a buy rating and a $40.00 price target on […]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s stock price was up 5.1% during trading on Thursday . The stock traded as high as $2.86 and last traded at $2.86. Approximately 47,066 shares traded hands during trading, a decline of 98% from the average daily volume of 2,712,542 shares. The stock had previously closed […]